Skip to main content
Erschienen in: The Cerebellum 2/2011

01.06.2011

Sleep Disorders in Machado–Joseph Disease: Frequency, Discriminative Thresholds, Predictive Values, and Correlation with Ataxia-Related Motor and Non-Motor Features

verfasst von: José Luiz Pedroso, Pedro Braga-Neto, André Carvalho Felício, Lívia Almeida Dutra, William A. C. Santos, Gilmar Fernandes do Prado, Orlando Graziani Povoas Barsottini

Erschienen in: The Cerebellum | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Sleep disorders are common complaints in patients with neurodegenerative diseases such as spinocerebellar ataxia type 3 (SCA3) or Machado–Joseph disease (MJD)—SCA3/MJD. We evaluated the frequency of sleep disorders in SCA3/MJD patients against controls matched by age and gender, and correlated data with demographic and clinical variables. The main sleep disorders evaluated were rapid eye movement (REM) sleep behavior disorder (RBD), restless leg syndrome (RLS), and excessive daytime sleepiness (EDS). We recruited 40 patients with clinical and molecular-proven SCA3/MJD and 38 controls. We used the following clinical scales to evaluate our primary outcome measures: RBD Screening Questionnaire, International RLS Rating Scale, and Epworth Sleepiness Scale. To evaluate ataxia-related motor and non-motor features, we applied the International Cooperative Ataxia Rating Scale, the Scale for the Assessment and Rating of Ataxia, and the Unified Parkinson’s Disease Rating Scale part III. Psychiatric manifestations were tested with the Hamilton Anxiety Scale, and Beck Depression Inventory. The frequency of RBD and RLS were significantly higher in the SCA3/MJD group than in the control group (p < 0.001). There was no difference between both groups with regard to EDS. The accuracy of RDBSQ to discriminate between cases and controls was considered the best area under the ROC curve (0.86). Within-SCA3/MJD group analysis showed that anxiety and depression were significantly correlated with RDB, but not with RLS. Additionally, depression was considered the best predictive clinical feature for RDB and EDS.
Literatur
1.
Zurück zum Zitat Schols L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol. 2004;3:291–304.PubMedCrossRef Schols L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol. 2004;3:291–304.PubMedCrossRef
2.
Zurück zum Zitat Rüb U, Brunt ER, Deller T. New Insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado Joseph disease). Curr Opin Neurol. 2008;21:111–16.PubMedCrossRef Rüb U, Brunt ER, Deller T. New Insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado Joseph disease). Curr Opin Neurol. 2008;21:111–16.PubMedCrossRef
3.
Zurück zum Zitat Schols L, Haan J, Riess O, Amoiridis G, Przuntek H. Sleep disturbance in spinocerebellar ataxias—is the SCA 3 mutation a cause of restless legs syndrome? Neurology. 1998;51:1603–07.PubMed Schols L, Haan J, Riess O, Amoiridis G, Przuntek H. Sleep disturbance in spinocerebellar ataxias—is the SCA 3 mutation a cause of restless legs syndrome? Neurology. 1998;51:1603–07.PubMed
4.
Zurück zum Zitat Reimold M et al. Spinocerebellar ataxia type 1, 2 and 3 and restless legs syndrome: striatal dopamine D2 receptor status investigated by [11C]raclopride positron emission tomography. Mov Disord. 2006;21:1667–73.PubMedCrossRef Reimold M et al. Spinocerebellar ataxia type 1, 2 and 3 and restless legs syndrome: striatal dopamine D2 receptor status investigated by [11C]raclopride positron emission tomography. Mov Disord. 2006;21:1667–73.PubMedCrossRef
5.
Zurück zum Zitat D'Abreu A, Friedman J, Coskun J. Non-movement disorder heralds symptoms of Machado Joseph disease years before ataxia. Mov Disord. 2005;20:739–41.PubMedCrossRef D'Abreu A, Friedman J, Coskun J. Non-movement disorder heralds symptoms of Machado Joseph disease years before ataxia. Mov Disord. 2005;20:739–41.PubMedCrossRef
6.
Zurück zum Zitat D'Abreu A, França Jr M, Conz L, et al. Sleep symptoms and their clinical correlates in Machado–Joseph disease. Acta Neurol Scand. 2009;119:277–80.PubMedCrossRef D'Abreu A, França Jr M, Conz L, et al. Sleep symptoms and their clinical correlates in Machado–Joseph disease. Acta Neurol Scand. 2009;119:277–80.PubMedCrossRef
7.
Zurück zum Zitat Iranzo A, Munoz E, Santamaria J, et al. REM sleep behavior disorder and vocal cord paralysis in Machado–Joseph disease. Mov Disord. 2003;18:1179–83.PubMedCrossRef Iranzo A, Munoz E, Santamaria J, et al. REM sleep behavior disorder and vocal cord paralysis in Machado–Joseph disease. Mov Disord. 2003;18:1179–83.PubMedCrossRef
8.
Zurück zum Zitat Iranzo A. Sleep and breathing in multiple system atrophy. Curr Treat Options Neurol. 2007;9:347–53.PubMed Iranzo A. Sleep and breathing in multiple system atrophy. Curr Treat Options Neurol. 2007;9:347–53.PubMed
9.
Zurück zum Zitat Schols L, Linnermann C, Globas C. Electrophysiology in spinocerebellar ataxias: spread of disease and characteristic findings. Cerebellum. 2008;7:198–03.PubMedCrossRef Schols L, Linnermann C, Globas C. Electrophysiology in spinocerebellar ataxias: spread of disease and characteristic findings. Cerebellum. 2008;7:198–03.PubMedCrossRef
10.
Zurück zum Zitat Vecchierini MF. Sleep disturbances in Alzheimer's disease and other dementias. Psychol Neuropsychiatr Vieil. 2010;8:15–23.PubMed Vecchierini MF. Sleep disturbances in Alzheimer's disease and other dementias. Psychol Neuropsychiatr Vieil. 2010;8:15–23.PubMed
11.
Zurück zum Zitat Videnovic A, Leurgans S, Fan W, Jaglin J, Shannon KM. Daytime somnolence and nocturnal sleep disturbances in Huntington disease. Parkinsonism Relat Disord. 2009;15:471–74.PubMedCrossRef Videnovic A, Leurgans S, Fan W, Jaglin J, Shannon KM. Daytime somnolence and nocturnal sleep disturbances in Huntington disease. Parkinsonism Relat Disord. 2009;15:471–74.PubMedCrossRef
12.
Zurück zum Zitat Friedman JH, Fernandez HH, Sudarsky LR. REM behavior disorder and excessive daytime somnolence in Machado–Joseph disease (SCA-3). Mov Disord. 2003;18:1520–22.PubMedCrossRef Friedman JH, Fernandez HH, Sudarsky LR. REM behavior disorder and excessive daytime somnolence in Machado–Joseph disease (SCA-3). Mov Disord. 2003;18:1520–22.PubMedCrossRef
13.
Zurück zum Zitat D'Abreu A, França Jr MC, Paulson HL, Lopes-Cendes I. Caring for Machado Joseph disease: current understanding and how to help patients. Parkinsonism Relat Disord. 2010;16:2–7.PubMedCrossRef D'Abreu A, França Jr MC, Paulson HL, Lopes-Cendes I. Caring for Machado Joseph disease: current understanding and how to help patients. Parkinsonism Relat Disord. 2010;16:2–7.PubMedCrossRef
14.
Zurück zum Zitat Braga-Neto P, Godeiro-Junior C, Dutra LA, Pedroso JL, Barsottini OGP. Translation and validation into Brazilian version of the Scale of the Assessment and Rating of Ataxia (SARA). Arq Neuropsiquiatr. 2010;68:228–30.PubMedCrossRef Braga-Neto P, Godeiro-Junior C, Dutra LA, Pedroso JL, Barsottini OGP. Translation and validation into Brazilian version of the Scale of the Assessment and Rating of Ataxia (SARA). Arq Neuropsiquiatr. 2010;68:228–30.PubMedCrossRef
15.
Zurück zum Zitat Schmitz-Hubsch T et al. Scale for the assessment and rating of ataxia—development of a new clinical scale. Neurology. 2006;66:1717–20.PubMedCrossRef Schmitz-Hubsch T et al. Scale for the assessment and rating of ataxia—development of a new clinical scale. Neurology. 2006;66:1717–20.PubMedCrossRef
16.
Zurück zum Zitat Stiasny-Kolster K, Mayer G, Schafer S, et al. The REM sleep behavior disorder screening questionnaire – a new diagnostic instrument. Mov Disord. 2007;22:2386–93.PubMedCrossRef Stiasny-Kolster K, Mayer G, Schafer S, et al. The REM sleep behavior disorder screening questionnaire – a new diagnostic instrument. Mov Disord. 2007;22:2386–93.PubMedCrossRef
17.
Zurück zum Zitat Masuko AH, Carvalho LB, Machado MA, et al. Translation and validation into the Brazilian Portuguese of the restless legs syndrome rating scale of the International Restless Legs Syndrome Study group. Arq Neuropsiquiatr. 2008;66:832–36.PubMedCrossRef Masuko AH, Carvalho LB, Machado MA, et al. Translation and validation into the Brazilian Portuguese of the restless legs syndrome rating scale of the International Restless Legs Syndrome Study group. Arq Neuropsiquiatr. 2008;66:832–36.PubMedCrossRef
18.
Zurück zum Zitat Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome diagnosis and epidemiology workshop at the national institutes of health; international restless legs syndrome study group. restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4:101–19.PubMedCrossRef Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome diagnosis and epidemiology workshop at the national institutes of health; international restless legs syndrome study group. restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4:101–19.PubMedCrossRef
19.
Zurück zum Zitat Iranzo A, Comella CL, Santamaria J, Oertel W. Restless legs syndrome in Parkinson's disease and other neurodegenerative diseases of the central nervous system. Mov Disord. 2007;22:424–30.CrossRef Iranzo A, Comella CL, Santamaria J, Oertel W. Restless legs syndrome in Parkinson's disease and other neurodegenerative diseases of the central nervous system. Mov Disord. 2007;22:424–30.CrossRef
21.
Zurück zum Zitat Dang D, Cunnington D. Excessive daytime somnolence in spinocerebellar ataxia type 1. J Neurol Sci. 2010;290:146–47.PubMedCrossRef Dang D, Cunnington D. Excessive daytime somnolence in spinocerebellar ataxia type 1. J Neurol Sci. 2010;290:146–47.PubMedCrossRef
22.
Zurück zum Zitat Cecchin CR, Pires AP, Rieder CR, et al. Depressive symptoms in Machado Joseph Disease (SCA3) patients and their relatives. Community Genet. 2007;10:19–26.PubMedCrossRef Cecchin CR, Pires AP, Rieder CR, et al. Depressive symptoms in Machado Joseph Disease (SCA3) patients and their relatives. Community Genet. 2007;10:19–26.PubMedCrossRef
23.
Zurück zum Zitat Kawai Y, Takeda A, Abe Y, et al. Cognitive impairments in Machado–Joseph disease. Arch Neurol. 2004;61:1757–60.PubMedCrossRef Kawai Y, Takeda A, Abe Y, et al. Cognitive impairments in Machado–Joseph disease. Arch Neurol. 2004;61:1757–60.PubMedCrossRef
24.
Zurück zum Zitat McMurtray AM, Clark DG, Flood MK, Perlman S, Mendez MF. Depressive and memory symptoms as presenting features of spinocerebellar ataxia. J Neuropsychiatry Clin Neurosci. 2006;18:420–22.PubMedCrossRef McMurtray AM, Clark DG, Flood MK, Perlman S, Mendez MF. Depressive and memory symptoms as presenting features of spinocerebellar ataxia. J Neuropsychiatry Clin Neurosci. 2006;18:420–22.PubMedCrossRef
26.
Zurück zum Zitat Yen T, Lu C, Tzen K, et al. Decreased dopamine transporter binding in Machado–Joseph disease. J Nucl Med. 2000;41:994–8.PubMed Yen T, Lu C, Tzen K, et al. Decreased dopamine transporter binding in Machado–Joseph disease. J Nucl Med. 2000;41:994–8.PubMed
27.
Zurück zum Zitat Remy P, Doder M, Lees A, Turjanski N, Brooks D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain. 2005;128:1314–22.PubMedCrossRef Remy P, Doder M, Lees A, Turjanski N, Brooks D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain. 2005;128:1314–22.PubMedCrossRef
Metadaten
Titel
Sleep Disorders in Machado–Joseph Disease: Frequency, Discriminative Thresholds, Predictive Values, and Correlation with Ataxia-Related Motor and Non-Motor Features
verfasst von
José Luiz Pedroso
Pedro Braga-Neto
André Carvalho Felício
Lívia Almeida Dutra
William A. C. Santos
Gilmar Fernandes do Prado
Orlando Graziani Povoas Barsottini
Publikationsdatum
01.06.2011
Verlag
Springer-Verlag
Erschienen in
The Cerebellum / Ausgabe 2/2011
Print ISSN: 1473-4222
Elektronische ISSN: 1473-4230
DOI
https://doi.org/10.1007/s12311-011-0252-7

Weitere Artikel der Ausgabe 2/2011

The Cerebellum 2/2011 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.